GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 2 | -99.5% | 0.00% | – |
Q4 2021 | $12,000 | +20.0% | 409 | +2.2% | 0.00% | – |
Q3 2021 | $10,000 | -28.6% | 400 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $14,000 | -17.6% | 400 | -5.9% | 0.00% | 0.0% |
Q1 2021 | $17,000 | -26.1% | 425 | -19.4% | 0.00% | 0.0% |
Q4 2020 | $23,000 | +4.5% | 527 | +31.8% | 0.00% | 0.0% |
Q3 2020 | $22,000 | -12.0% | 400 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $25,000 | +25.0% | 400 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $20,000 | -39.4% | 400 | -4.5% | 0.00% | 0.0% |
Q4 2019 | $33,000 | +37.5% | 419 | -16.2% | 0.00% | 0.0% |
Q3 2019 | $24,000 | -35.1% | 500 | -28.6% | 0.00% | -50.0% |
Q2 2019 | $37,000 | +42.3% | 700 | +40.0% | 0.00% | +33.3% |
Q1 2019 | $26,000 | +30.0% | 500 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $20,000 | -25.9% | 500 | -28.6% | 0.00% | 0.0% |
Q3 2018 | $27,000 | -12.9% | 700 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $31,000 | -8.8% | 700 | 0.0% | 0.00% | -20.0% |
Q1 2018 | $34,000 | -20.9% | 700 | -36.4% | 0.01% | -28.6% |
Q4 2017 | $43,000 | 0.0% | 1,100 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $43,000 | +48.3% | 1,100 | 0.0% | 0.01% | +40.0% |
Q2 2017 | $29,000 | -56.1% | 1,100 | -50.0% | 0.01% | -28.6% |
Q1 2017 | $66,000 | +266.7% | 2,200 | +76.0% | 0.01% | +75.0% |
Q4 2016 | $18,000 | – | 1,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |